tiprankstipranks
Trending News
More News >

SSY Group Gains Approval for Arbidol Hydrochloride Tablets

Story Highlights
SSY Group Gains Approval for Arbidol Hydrochloride Tablets

Confident Investing Starts Here:

SSY Group ( (HK:2005) ) has shared an update.

SSY Group Limited has received approval from China’s National Medical Products Administration for the production and registration of Arbidol Hydrochloride Tablets, a drug used to treat various viral infections including influenza and coronavirus-related illnesses. This approval marks a significant step in the company’s product development, potentially enhancing its market position and offering new treatment options for respiratory infections.

More about SSY Group

SSY Group Limited operates in the pharmaceutical industry, focusing on the development and production of chemical drugs. The company is involved in the manufacture of both bulk drugs and finished products, with a market focus on treatments for viral infections.

YTD Price Performance: -6.47%

Technical Sentiment Signal: Buy

Current Market Cap: $1.2B

For a thorough assessment of 2005 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App